Goldberg Mark Alan

CIK 00015324757 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001532475

Recent Transactions

50 trades

Disposition from Tender
Blueprint Medicines Corp
Common Stock
2025-07-17−18,254→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−10,909→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−5,300→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−4,570→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−4,500→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−4,500→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Common Stock
2025-07-17−3,902→ 18,254 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−7,500→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−5,300→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−4,875→ 0 total
Award
Blueprint Medicines Corp
Common Stock
2025-06-18$128.12/sh+3,902→ 22,156 total
Award
Blueprint Medicines Corp
Common Stock
2024-06-12+2,242→ 18,254 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-06-12+4,570→ 4,570 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Stock Option (right to buy)
2024-05-01+40,000→ 40,000 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2024-03-29$3.00/sh+4,584→ 24,828 total
Disposition to Issuer
ImmunoGen, Inc.
Common Stock
2024-02-12−60,720→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−44,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−50,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−5,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−19,597→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−44,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−18,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−18,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−10,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−10,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−10,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Deferred Share Unit
2024-02-12−160,350→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Restricted Stock Unit
2024-02-12−13,090→ 0 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Common stock
2023-12-29$2.36/sh+5,827→ 20,244 total
Award
ImmunoGen, Inc.
Common Stock
2023-12-29$29.65/sh+569→ 60,720 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-10-30−10,000→ 0 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-10-30$15.08/sh−10,000→ 60,151 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-10-30$14.70/sh+10,000→ 70,151 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Common stock
2023-09-30$1.50/sh+9,167→ 14,417 total
Award
ImmunoGen, Inc.
Common Stock
2023-09-29$15.87/sh+1,063→ 60,151 total
Award
ImmunoGen, Inc.
Common Stock
2023-06-30$18.87/sh+894→ 59,088 total
Award
Blueprint Medicines Corp
Common Stock
2023-06-21+2,600→ 16,012 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2023-06-21+5,300→ 5,300 total
Award
ImmunoGen, Inc.
Stock Option (right to buy)
2023-06-14+19,597→ 19,597 total
Award
ImmunoGen, Inc.
Restricted Stock Unit
2023-06-14+13,090→ 13,090 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Stock Option (right to buy)
2023-05-19+35,000→ 35,000 total
Award
ImmunoGen, Inc.
Common Stock
2023-03-31$3.84/sh+4,394→ 58,194 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2022-12-30+3,402→ 160,350 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2022-09-30+3,530→ 156,948 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2022-06-30+3,750→ 153,418 total
Award
Aceragen, Inc.
Stock Option (Right to Buy)
2022-06-23+26,000→ 26,000 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2022-06-21+5,300→ 5,300 total
Award
Blueprint Medicines Corp
Common Stock
2022-06-21+2,600→ 13,412 total
Award
ImmunoGen, Inc.
Stock Option (right to buy)
2022-06-15$3.37/sh+44,000→ 44,000 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2022-06-15+15,000→ 149,668 total

Companies

Recent Filings

Address

SYNAGEVA BIOPHARMA CORP. 128 SPRING ST STE 520

LEXINGTON, MA, 02421

View on SEC.gov